Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Carisma Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +30 vs. Q1 2021
- Shares held
- 66.2M
- +26.1M (+65.0%) vs. Q1 2021
- Total value
- $305.9M
- +$201.6M (+193.1%) vs. Q1 2021
- New holders
- 43
- 31 more added
- Sold out
- 13
- 21 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 3 | $47.9K |
| Q4 2025 | 7 | $67.0K |
| Q3 2025 | 33 | $842.6K |
| Q2 2025 | 36 | $1.56M |
| Q1 2025 | 37 | $1.73M |
| Q4 2024 | 41 | $2.35M |
| Q3 2024 | 37 | $5.11M |
| Q2 2024 | 53 | $9.28M |
| Q1 2024 | 51 | $19.3M |
| Q4 2023 | 50 | $26.4M |
| Q3 2023 | 58 | $39.6M |
| Q2 2023 | 53 | $84.0M |
| Q1 2023 | 37 | $17.3M |
| Q4 2022 | 71 | $19.8M |
| Q3 2022 | 69 | $11.0M |
| Q2 2022 | 74 | $23.1M |
| Q1 2022 | 84 | $26.4M |
| Q4 2021 | 93 | $39.1M |
| Q3 2021 | 103 | $44.5M |
| Q2 2021 | 106 | $305.9M |
| Q1 2021 | 76 | $104.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 3,150,574 | $14.6M | 0.04% | −67,245−2.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 3,828,200 | $17.7M | 0.20% | +474,110+14.1% | Added |
| TRV GP, LLC | 4,091,591 | $18.9M | 100.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 8,503,982 | $39.3M | 0.00% | +1,308,430+18.2% | Added |
| BlackRock Inc. | 10,657,812 | $49.2M | 0.00% | +7,735,364+264.7% | Added |
| State Street Corp | 13,675,800 | $63.2M | 0.00% | +13,558,500+11,558.8% | Added |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,311,672−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −379,285−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −262,181−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −251,351−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −156,027−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −151,902−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −100,994−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −44,977−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −43,690−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −42,158−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −17,400−100.0% | Sold out |